132 related articles for article (PubMed ID: 27902464)
21. Neural Wiskott-Aldrich syndrome protein (nWASP) is implicated in human lung cancer invasion.
Frugtniet BA; Martin TA; Zhang L; Jiang WG
BMC Cancer; 2017 Mar; 17(1):224. PubMed ID: 28351346
[TBL] [Abstract][Full Text] [Related]
22. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
23. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A.
Quan Y; Song Q; Wang J; Zhao L; Lv J; Gong S
Tumour Biol; 2017 Apr; 39(4):1010428317697565. PubMed ID: 28443461
[TBL] [Abstract][Full Text] [Related]
24. Prognosis, Significance and Positive Correlation of Rab1A and p-S6K/Gli1 Expression in Gastric Cancer.
Shao X; Cheng Z; Xu M; Mao J; Wang J; Zhou C
Anticancer Agents Med Chem; 2019; 19(11):1359-1367. PubMed ID: 31038077
[TBL] [Abstract][Full Text] [Related]
25. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
26. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of inflammasomes in lung cancer cell lines and tissues.
Kong H; Wang Y; Zeng X; Wang Z; Wang H; Xie W
Tumour Biol; 2015 Sep; 36(10):7501-13. PubMed ID: 25910707
[TBL] [Abstract][Full Text] [Related]
28. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
29. Pooled analysis of prognostic value and clinical significance of Rab1A expression in human solid tumors.
Shao X; Cheng Z; Xu M; Tan Z; Gao L; Wang J; Zhou C
Medicine (Baltimore); 2019 Dec; 98(50):e18370. PubMed ID: 31852145
[TBL] [Abstract][Full Text] [Related]
30. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
[TBL] [Abstract][Full Text] [Related]
31. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
[TBL] [Abstract][Full Text] [Related]
32. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of axin downregulates TCF-4 and inhibits the development of lung cancer.
Xu HT; Wei Q; Liu Y; Yang LH; Dai SD; Han Y; Yu JH; Liu N; Wang EH
Ann Surg Oncol; 2007 Nov; 14(11):3251-9. PubMed ID: 17768662
[TBL] [Abstract][Full Text] [Related]
34. A detailed immunohistochemical analysis of the PI3K/AKT/mTOR pathway in lung cancer: correlation with PIK3CA, AKT1, K-RAS or PTEN mutational status and clinicopathological features.
Trigka EA; Levidou G; Saetta AA; Chatziandreou I; Tomos P; Thalassinos N; Anastasiou N; Spartalis E; Kavantzas N; Patsouris E; Korkolopoulou P
Oncol Rep; 2013 Aug; 30(2):623-36. PubMed ID: 23728071
[TBL] [Abstract][Full Text] [Related]
35. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
[TBL] [Abstract][Full Text] [Related]
36. 14-3-3ζ/TGFβR1 promotes tumor metastasis in lung squamous cell carcinoma.
Zhao Y; Qiao W; Wang X; Yin H; Cui J; Cui Y; Chen X; Hu J; Lu H; Meng Q; Wang Y; Cai L
Oncotarget; 2016 Dec; 7(50):82972-82984. PubMed ID: 27764818
[TBL] [Abstract][Full Text] [Related]
37. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer.
Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW
Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of DUSP6 with expression of ERK and Ki-67 in non-small cell lung carcinoma.
Lee H; Kim JM; Huang SM; Park SK; Kim DH; Kim DH; Lee CS; Suh KS; Yi ES; Kim KH
Pathol Res Pract; 2011 Jul; 207(7):428-32. PubMed ID: 21680106
[TBL] [Abstract][Full Text] [Related]
40. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
